HomeProductsBioactive CompoundsImmunology & InflammationHistamine ReceptorBilastine
Chemical structure of CAS 202189-78-4

Bilastine

In Stock•Starting at $18 for 5 mg•Purity ≥ 98%
CAS No.202189-78-4
MDL No.N/A
MFC28H37N3O3
MW463.60
InChI KeyACCMWZWAEFYUGZ-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg98%$18In Stock
10 mg98%$24In Stock
50 mg98%$29In Stock
100 mg98%$38In Stock
250 mg98%$55In Stock
1 g98%$124In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Bilastine is a benzimidazole.

CAS No.202189-78-4
Product NameBilastine
IrritantIrritant
Signal Word:Warning
HCode:H302-H312-H332
PCode:P261-P264-P270-P271-P280-P301+P317-P302+P352-P304+P340-P317-P321-P330-P362+P364-P501

Related Articles

Studies related to this compound and its mechanism of action

Chemistry, Pharmacokinetics, Pharmacodynamics and Analytical Methods of Bilastine, a Histamine H1 Receptor Antagonist: An Update.

Mini reviews in medicinal chemistry • Vol. 21, Issue 20 • 2021
PMID: 33992058DOI: 10.2174/1389557521666210520171457

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine.

Therapeutics and clinical risk management • Vol. 12 • 2016
PMID: 27110120PMC: PMC4835134DOI: 10.2147/TCRM.S105189

Bilastine: a new nonsedating oral H1 antihistamine for treatment of allergic rhinoconjunctivitis and urticaria.

BioMed research international • Vol. 2013 • 2013
PMID: 23956994PMC: PMC3728546DOI: 10.1155/2013/626837

Preclinical toxicity profile of oral bilastine.

Drug and chemical toxicology • Vol. 35 Suppl 1 • 2012
PMID: 22616813DOI: 10.3109/01480545.2012.682652

Documentation

Similar Products